Lexeo Therapeutics (LXEO) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.99
-0.86
-0.73
-0.6

Details

Expected EPS
-0.679386
Actual EPS
-0.6
Surprise EPS
0.08
Surprise Percent
+11.68%

Description

Lexeo Therapeutics (LXEO) has reported earnings of -0.6 per share for Q3 2025.

0 Comments

Share your thoughts